October 20, 2014: Here's BioSpace's guide to who's working on therapeutics or vaccines for Ebola and how those pipelines are progressing. Companies that are not included in the list but are also developing Ebola treatments are encouraged to contact BioSpace.
October 20, 2014: NewLink Genetics Corp. is having a banner month. Thel company announced today that it has inked a deal potentially worth $1 billion with Genentech, a member of the Roche Group, for the development of NLG919, NewLink's IDO pathway inhibitor.
October 20, 2014: Allergan Inc., maker of Botox, filed on Friday with the California Employment Development Department, indicating they will lay off 40 employees in Carlsbad, Calif.
October 20, 2014: Irish biotech Shire Pharmaceuticals is rebounding from the breakup of its $55 billion merger with drugmaker AbbVie by doing some shopping itself, news outlets reported over the weekend.